Valerie Pauwels

Assoc Dir, Product Management Cell Therapy

“I’m driven to bring innovative therapies to patients in need. More particularly, within the team I’m responsible for delivering a clear and comprehensive communication on Yescarta® and the CAR-T process."

Bart Jacobs

Assoc. Dir. Medical

I joined this team to help more patients access a potentially life-saving therapy in the form of CAR-T cells, by closely collaborating with the medical community in Belgium.

Mario De Moor

Cell Therapy Account Manager

I’m looking forward to contribute to make a difference for patients and healthcare professionals. After 1L treatment, every patient who is CAR-T-eligible , must have access to YESCARTA, and experience this innovative treatment as a chance for a new future.

Anne Marie Omogrosso

Sr Cell Therapy Account Manager

Having a long experience in haematology, I feel privileged to be able to present and represent CART, Yescarta and Tecartus. The 2L results in patients suffering from diffuse B lymphoma are breathtaking, and will breathe new life into the treatment of these patients.

Olivier Suys

Assoc. Case Manager

Dedicated to making a meaningful impact on the healthcare of patients with lymphoma and leukemia by providing seamless and high-quality logistical support for the delivery of our innovative CAR T cell therapy treatments

Ruth Van Daele

Medical Manager

I am proud to be part of a dedicated team working to bring innovative cell therapies to the patients who need them. Through collaboration with the scientific and clinical field, we strive to optimize cancer care for patients with hematological malignancies.

Charlotte Kluit

Business Unit Director Cell Therapy

As Business Unit Director for Cell Therapy, I lead our efforts to ensure Kite’s CAR T cell therapies reach patients quickly and safely. By partnering with you, we streamline care pathways, provide education, and deliver the support needed throughout the treatment journey.